Sources Sought Notice: H23-2521 – 126553-B1073 Mold Remediation
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
General Information
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Jun 22, 2023 03:29 pm EDT
- Original Response Date: Jul 24, 2023 03:00 pm EDT
- Inactive Policy: Manual
- Original Inactive Date: Feb 11, 2025
- Initiative:
Classification
- Original Set Aside:
- Product Service Code:
- NAICS Code:
- Place of Performance:
Description
Biomed) for the National Cancer Institute requires construction services for the mold remediation in Building 1073 to include relocating LN2 freezers to B314 and new LN2 piping in Building 1066
For information concerning opportunities with the FNLCR, please refer to:
Add link to the FNLCR Work with Us website i.e. https://frederick.cancer.gov/collaborations and contact the Leidos Biomedical Research Point of Contact listed in this announcement.
Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD.
Leidos Biomedical Research, Inc. POC: Sr. Subcontract Administrator at traci.leaman@nih.gov
Attachments/Links
Contact Information
Contracting Office Address
- OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
- Bethesda , MD 20892
- USA
Primary Point of Contact
- Traci Parlett-Leaman
- traci.leaman@nih.gov
Secondary Point of Contact
History
- Jul 03, 2023 11:22 am EDTSpecial Notice (Updated)
- Jun 22, 2023 03:29 pm EDTSpecial Notice (Original)